Pamicell Secures Large-Scale Nucleoside Supply Contract... Full-Scale Development of RNA Therapeutics Begins
[Asia Economy Reporter Hyungsoo Park] Pharmicell announced on the 21st that it received an order worth approximately $8.53 million (about 10.2 billion KRW) for nucleosides from ThermoFisher Scientific in the United States.
Nucleosides are used for mRNA vaccine purification, virus diagnostic kits, genetic diagnostic reagents, and RNA-based gene therapies.
A Pharmicell official stated, "Recently, there has been a continuous large-scale order of nucleosides," adding, "This is interpreted as an increase in demand for nucleosides, the raw material, as RNA therapeutic development is accelerating."
Hot Picks Today
"How Much Will They Get?" 600 Million vs. 460 Million vs. 160 Million... Samsung Electronics DS Division's 'Three Wallets Under One Roof'
- Opening a Bank Account in Korea Is Too Difficult..."Over 150,000 Won in Notarization Fees Just for a Child's Account and Debit Card" [Foreigner K-Finance Status]②
- Samsung Electronics Labor-Management Agreement, Nvidia Revenue Surges... KOSPI Soars Over 6%
- "Disappointing Results: 80% of Sunscreens Found Lacking in Safety and Effectiveness"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
He continued, "The cumulative sales until the third quarter of this year reached 39.1 billion KRW, exceeding last year's annual sales of 37.8 billion KRW," and added, "As the RNA therapeutic market is becoming more active, the sales growth of raw pharmaceutical materials is expected to continue next year."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
!["Please Help Us": How Much Do Those Bowing Deeply for Your Vote Really Earn? [Data Pick]](https://cwcontent.asiae.co.kr/asiaresize/307/2026052010120870131_1779239528.png)
